Hepatitis bars China toddlers from kindergarten

BEIJING (Reuters) - A group of 101 mothers have written to China’s Communist Party leadership for help after their toddlers were denied kindergarten places for testing positive for hepatitis B.

China has passed laws in recent years reversing a ban on its 120-130 million hepatitis B carriers from the civil service, and banning companies from using the virus as an excuse to fire or not hire.

But activists and sufferers say discrimination and stigma fueled by ignorance remain widespread and a number of provincial governments still have laws banning carriers from kindergartens, despite minimal chances of infection from casual contact.

“Our children have already been unfortunate enough to be infected with hepatitis B, and yet to be treated with such discrimination they cannot receive a normal pre-school education,” said a transcript of the letter carried in the Beijing News on Thursday.

“How will this affect our children’s lives? How will stigmatization affect their character and their growing into adults? We dare not think,” it added.

Li Hua, a mother from coastal Shandong province, said the letter targeted Liu Yandong, a female member of China’s cabinet, the State Council, with an education portfolio.

“We thought of writing to Premier Wen Jiabao but thought he might be too busy… Then we thought of Liu Yandong because she is the only woman on the State Council… is possibly a mother herself, and can more deeply understand our feelings,” Li told Reuters by telephone.

Hepatitis B is usually transmitted from mother to child, but can be passed on through sex, blood transfusions and contaminated needles.

While older children and adults can flush out the virus, children under five usually end up carrying it for life. One in four are at risk of developing cirrhosis — scarring of the liver — or liver cancer later in life.  Continued…


Related Posts:

BEIJING (Reuters) - China has ordered a hemorrhoid medicine off pharmacy shelves over fears the capsules were to blame for liver problems, state media reported on Wednesday. The State Food and Drug Administration (SFDA) demanded the nationwide recall of the “Zhixue” capsules made by Vital Pharmaceutical Holdings Ltd in southwest China, Xinhua news agency reported. Twenty-one people

Full Post: China recalls capsules suspected of liver damage

NEW YORK (Reuters Health) - Hepatitis A infections, usually transmitted via contaminated food, can cause debilitating illness, but protection afforded by the hepatitis A vaccine last more than a decade, a new study shows. In fact, antibodies against hepatitis A virus persist for up to 27 years after vaccination, report investigators from the Centers for Disease

Full Post: Hepatitis A vaccine gives long-lasting protection

By Julie Steenhuysen CHICAGO (Reuters) - Doctors hope to be able to better predict which patients will respond to traditional treatment for the hepatitis C virus using a new method for identifying slight variances in the virus’ genetic makeup. U.S. researchers said on Monday that the technique may prove useful for other viruses such as HIV as

Full Post: Study may predict if hepatitis C drugs will work

NEW YORK (Reuters Health) - In patients with advanced chronic hepatitis C infection who have not responded to prior therapy with the standard combination drug treatment — peginterferon and ribavirin — prolonged low-dose, or “maintenance” therapy does not reduce the rate of disease progression, new research shows. Patients who do not respond to initial antiviral therapy

Full Post: No benefit of extended hepatitis C therapy for some

BEIJING (Reuters) - Three children have died in eastern China from hand, foot and mouth disease in the country’s second outbreak of the potent toddler virus this year, state media reported on Monday. Health officials warned that the disease was epidemic in some parts of the coastal Fujian province, with 113 cases reported since the start

Full Post: Toddler virus flares up again in China, kills three

Site Navigation

Most Read



  • kinwrite.com@gmail.com